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Although CTLA-4 has sequence characteristics andKelly L. Bennett, and Robert S. Mittler
ligand binding properties of a plasma membrane recep-Bristol-Myers Squibb Pharmaceutical Research
tor (Harper et al., 1991), it is primarily an intracellularInstitute
membrane protein, characterized by polarized perinu-3005 First Avenue
clear expression (Leung et al., 1995). In transfected cells,Seattle, Washington 98121
the intracellular localization of CTLA-4 was regulated by
a tyrosine-containing 11 aa motif in its cytoplasmic tail.
This motif targeted CTLA-4 to a Golgi or post-Golgi
Summary compartment (Leung et al., 1995), thereby limiting its
expression at the cell surface.
T lymphocyte receptor CTLA-4 binds costimulatory The intracellular localization of CTLA-4 contrasts with
its presumed function as a cell surface receptor andmolecules CD80 (B7-1) and CD86 (B7-2) with high avid-
raises several questions about how this molecule func-ity and negatively regulates T cell activation. CTLA-4
tions during T cell activation. One question is whetherfunctions at the cell surface, yet is primarily localized
the small amount of CTLA-4 found on the cell surfacein intracellular vesicles. Here, we demonstrate cycling
under steady-state conditions is responsible for the bio-of CTLA-4 between intracellular stores and the cell
logical effects of CTLA-4. The preferential intracellularsurface. Intracellular vesicles containing CTLA-4 over-
localization of CTLA-4 may reflect the need to limit thelapped with endocytic compartment(s) and with per-
levels of this potent high avidity molecule expressed atforin-containing secretory granules. Cell surface ex-
the cell surface. Another question is whether expressionpression of CTLA-4 was rapidly increased by raising
of CTLA-4 at the cell surface is static, or whether it isintracellular calcium levels. During T cell activation,
dynamically regulated such that the molecule transits inintracellular and cell surface CTLA-4 became focused
response to environmental stimuli between intracellulartowards sites of TCR activation. Cycling and direc-
stores and the cell surface.tional control of CTLA-4 expression may regulate its
Finally, there is the question of whether intracellularfunctional interaction with APCs bearing peptide±
localization of CTLA-4 represents a mechanism(s) toMHC complexes of appropriate specificity and avidity.
direct the localization of its expression. Studies in both
lymphoid and nonlymphoid cells have shown that fol-
lowing cell±cell contact, the Golgi apparatus is typicallyIntroduction
reoriented such that it faces the site of cell contact
(Singer, 1992). This typically results in directional releaseFull activation of T cells requires engagement of the T
of secretory proteins such as cytokines (Poo et al., 1988;cell antigen receptor (TCR)±CD3 complex and ligation
Kupfer et al., 1991, 1994), or the contents of cytotoxicof costimulatory receptor(s) (Mueller et al., 1989). Among
granules (Berke, 1994) towards sites of cell±cell contact.the key costimulatory receptors are CD28 and CTLA-4,
Since secretory and membrane proteins share commonhomologous members of the immunoglobulin superfam-
pathway(s) of protein export, directional release of mem-ily, which bind B7-1 (CD80) and B7-2 (CD86) mole-
brane proteins such as CTLA-4 may also occur. In thiscules on antigen-presenting cells (APCs). Following en-
study, we have investigated the relationship between
gagement of their counterreceptors, CD28 and CTLA-4
intracellular and cell surface±localized CTLA-4. We
transmit signals important for optimal T cell activation
show that CTLA-4 expression at the cell surface is dy-
(Schwartz, 1992; Linsley and Ledbetter, 1993; Guinan namically and directionally regulated by continuous pro-
et al., 1994; June et al., 1994; Allison, 1994). CD28 has cesses of export and internalization.
low avidity for B7 molecules (Linsley et al., 1994) and is
expressed on resting and activated T cells. In contrast, Results
CTLA-4 has high avidity for B7 molecules (Linsley et
al., 1991, 1994) and is expressed on T cells only after Cycling of CTLA-4 Between Intracellular
activation (Brunet et al., 1987). CD28 and CTLA-4 appar- Stores and the Cell Surface
ently have different functions during T cell activation. Although CTLA-4 is expressed mainly in intracellular
CD28 triggering strongly up-regulates T cell cytokine vesicles, it might still cycle between the cell surface and
production and cellular activation (Schwartz, 1992; Lin- intracellular stores. If this were so, then anti-CTLA-4
sley and Ledbetter, 1993; Guinan et al., 1994; June et MAbs added to culture medium of CTLA-4-expressing
al., 1994; Allison, 1994). CTLA-4 triggering with specific cells should accumulate intracellularly, even though little
monoclonal antibodies (MAbs) does not produce the CTLA-4 is expressed at the cell surface. To test this
same effects (Linsley et al., 1992; Damle et al., 1994; possibility, we compared accumulation of BODIPY-con-
Walunas et al., 1994; Krummel and Allison, 1995), and jugated anti-CD28 and anti-CTLA-4 MAbs by phytohe-
may down-regulate CD28-mediated effects (Krummel magglutinin (PHA) blasts at 378C or 48C (Figure 1). When
and Allison, 1995). CTLA-4-deficient mice have a severe cells were incubated with BODIPY-conjugated anti-
lymphoproliferactive disorder, and show early lethality CD28 MAb, identical staining intensities were seen dur-
ing incubations from 1±4 hr at 378C or 48C (Figures 1A(Tivolet al., 1995; Waterhouse et al., 1995). Thus, CTLA-4
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Figure 2. Overlapping Distribution Between Transferrin-Containing
Endosomes and Internal Stores of CTLA-4
PHA blasts were incubated with 250 mg/ml TRTf (red fluorescence)
for 1 hr at 378C. Cells were washed, fixed, and premeabilized, and
internal stores of CTLA-4 were stained with BODIPY-conjugated
MAb 11D4 (green fluorescence). Cells were then fixed again and
examined by confocal microscopy. Areas of coincidence of red and
green fluorescence (giving yellow fluorescence) indicate overlap-
ping distribution of CTLA-4 and transferrin; some of these areas are
indicated by arrows. (A±D) represent serial optical sections throughFigure 1. Uptake of Anti-CTLA-4 MAb by Activated T Cells
the same cell, z1 mm apart.
(A and B) PHA blasts were incubated with BODIPY-conjugated anti-
CD28 MAb 9.3 at 378C (A) or 48C (B) for 1 hr (gray line), 2 hr (white
uptake was linear over a period of more than 4 hr (Figureline), or 4 hr (black line). Cells were then washed and a total of
10,000 cells was analyzed by flow cytometry. The shaded histo- 1E). In more than five separate experiments, the amount
grams represent autofluorescence of unstained samples. An addi- of cell-associated fluorescence doubled approximately
tional sample incubated at 378C for 3 hr has been omitted for clarity. every 1±2 hr. The rate of uptake of Fab fragments of
(C and D) PHA blasts were incubated for various periods of time
anti-CTLA-4 MAb was identical to that of intact MAbwith BODIPY-conjugated anti-CTLA-4 MAb 11D4 at 378C (C) or 48C
(Figure 1E), indicating that uptake did not require biva-(D). Labeling of the curves is as in (A) and (B).
lent MAb binding. Examination by confocal microscopy(E) The uptake of both BODIPY-conjugated whole anti-CTLA-4 11D4
of cells incubated at 378C with BODIPY-conjugated anti-MAb (closed symbols, solid line) and BODIPY-conjugated 11D4 Fab
(open symbols, dashed line) was measured in an experiment identi- CTLA-4 MAb (Figure 1F) or BODIPY Fab fragment (data
cal to the one shown in (C). Mean fluorescence intensities were not shown) revealed numerous fluorescence-tagged
plotted versus time of incubation at 378C. Similar results using intact vesicles or endosomes inside these cells. In contrast,
MAb were obtained in more than five separate experiments.
when cells were incubated with BODIPY-conjugated(F) Cells were incubated with BODIPY-conjugated MAb 11D4 at
anti-CD28 MAb, fluorescence was mainly cell surface378C for 3 hr, fixed, counterstained with propidium iodide (red fluo-
associated, as determined by confocal microscopyrescence), and examined by confocal microscopy. BODIPY-conju-
gated MAb was found in intracellular vesicles (green fluorescence, (data not shown). These results showed differential en-
indicated by arrows). docytosis of anti-CD28 and CTLA-4 MAbs. Anti-CTLA-4
MAb becomes internalized during incubation at 378C,
whereas anti-CD28 MAb primarily remains attached to
and 1B). The amount of cell-associated MAb at 4 hr was the cell surface.
reduced by treatment at pH 3, indicating that much of
it had been associated with the cell surface (data not Overlap Between Endosomes
shown). In contrast, cells incubated with anti-CTLA-4 and Intracellular CTLA-4
MAb 11D4 at 378C showed a time-dependent uptake of Data shown in Figure 1 suggested cycling of CTLA-4
labeled MAb (Figure 1C); cells incubated at 48C did not between the cell surface and intracellular stores. This
show this increase (Figure 1D). Other experiments (data would imply overlap between intracellular stores of
not shown) showed that this uptake was blocked by CTLA-4 and endosomal compartment(s). To test this
addition of CTLA-4Ig, indicating that it was antigen spe- possibility, we determined whether the distribution of
cific; and that cell-associated MAb after 4 hr was not intracellular CTLA-4 overlapped with that of endo-
released by treatment of cells at pH 3, suggesting that somes involved in the well-characterized endocytic
pathway involving transferrin and its receptor (Figure 2).it had been internalized. The rate of anti-CTLA-4 MAb
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PHA blasts were incubated with Texas Red±conju- permeabilization. In this case, numerous cells showed
CTLA-4 staining localized towards the coverslip (datagated transferrin (TRTf) to achieve steady-state labeling
not shown). We also compared the distribution of cellof transferrin receptor±containing endosomes. TRTf-
surface and intracellular CTLA-4 on the same cells.labeled cells were then fixed and permeabilized and
These cells showed heaviest accumulation of cell sur-stained for intracellular CTLA-4. As shown in Figure 2,
face staining next to the coverslip, as in Figure 3H, withthere was considerable overlap between TRTf-con-
lower intensity cell surface staining up from the planetaining endosomes and intracellularCTLA-4. Thus, intra-
of the coverslip. Intracellular staining was similar to thatcellular stores of CTLA-4 intersect with an endocytic
shown in Figure 3. We conclude that both intracellularcompartment(s).
and cell surface CTLA-4 have an unusual distribution
pattern, polarized towards the immobilizing/activating
MAb. In contrast, the distribution of CD28 was identicalFocal Localization of CTLA-4 Towards Sites
whether permeabilized cells or intact cells (data notof TCR Engagement
shown) were examined.Because of the reorientation of the Golgi apparatus that
To determine whether the polarized distribution oftypically accompanies cell±cell contact (Singer, 1992),
CTLA-4 was dependent upon immobilization or the acti-we hypothesized that during T cell activation, CTLA-4
vation stimulus, we immobilized lymphocytes on cham-expression might be preferentially localized towards the
bered slides coated with a nonactivating anti-CD18 (b2source of activating stimuli. Previous studies (Leung et
integrin) MAb. This did not lead to expression of CTLA-4al., 1995) showed a polarized distribution of CTLA-4
or the CD69 activation antigen. However, when anti-CD3in activated T cells. However, since these cells were
MAb-coated beads were added to immobilized cells,examined in solution, their orientation towards the acti-
expression of CTLA-4 and CD69 was detectable withinvating stimulus could not be determined.
48 hr. Examination of cells activated by adhesion toTo test for directional release of CTLA-4 during T cell
MAb-coated beads showed that CTLA-4 was not distrib-activation, we devised a system for examining the distri-
uted towards the coverslip, but directed towards anti-bution of lymphocyte membrane proteins relative to an
CD3-coated beads (Figure 4). Anti-CD3-coated beadsimmobilized activating antibody. This procedure was
were attached to many of the activated cells, and couldthen used todetermine the relative distributions of CD28
be visualized because of their faint fluorescence afterand CTLA-4. A typical experiment is shown in Figure 3.
staining with anti-CTLA-4 MAb; this staining was notPeripheral blood mononuclear cells were immobilized
seen with control immunoglobulin, and was perhapson chambered coverslips coated with anti-CD3 MAb.
due to association of membrane fragments containingAdherent cells were then stained for various markers
CTLA-4 with the anti-CD3-coated beads. In activatedand immunofluorescence was examined by confocal
cells bound by anti-CD3-coated beads, the distributionmicroscopy. The distribution of CD28 molecules on im-
of CTLA-4 was clearly oriented towards attached anti-mobilized cells was uniform and typical of a cell surface
CD3-coated beads (Figure 5). Thus, CTLA-4 was local-membrane protein; this was evident in both horizontal
ized preferentially towards the activating stimulus.
(Figures 3A±3C) and vertical (D) optical sections. In con-
It was important to determine whether polarized distri-
trast, CTLA-4 in permeabilized cells was distributed
bution of CTLA-4 in anti-CD3-activated cells was also
preferentially towards the sites of cell attachment to the
a feature of T cells activated in a more physiological
immobilized MAb (Figures 3E±3J). Intracellular CTLA-4 manner. Therefore, we tested whether CD41 cells acti-
expression was typically (in >z90% of positively stain- vated with alloantigen showed a polarized distribution
ing cells) beneath the nucleus, i.e., between the nucleus of CTLA-4. We previously have shown that the expres-
and the coverslip. In some cells (Figure 3H) CTLA-4 sion of CTLA-4 by these cells requires alloantigen stimu-
staining was very close to the plane of the cell surface lation, since without stimulation cells expressed <50
membrane, whereas in other cells, (I±J) it was more molecules/cell of CTLA-4; following stimulation, CTLA-4
broadly distributed beneath the nucleus. CD2 (Figure expression increases >250-fold (Linsley et al., 1992).
3K) and CD5 (L) showed typical surface fluorescence, Thus, expression of CTLA-4 by these cells indicates that
similar to CD28. In other experiments, CD4, CD25, and they have been activated by alloantigen. As shown in
CD69 also showed typical surface fluorescence distribu- Figure 5, CTLA-4 in these cells was oriented towards
tion, indicating that the focal distribution of CTLA-4 was alloantigen-bearing stimulator cells. The distribution of
not a general property of T cell activation antigens. CTLA-4 towards activating stimuli was thus similar when
Staining with CTLA-4Ig was also uniform, indicating that T cells were activated with anti-CD3 MAb or with alloan-
CD80/CD86 molecules on T cells (which bind CTLA-4Ig) tigen. This indicates that the polarized expression of
do not colocalize with CTLA-4 molecules. CTLA-4 during contact with APCs does not require inter-
The experiment shown in Figure 3 thus demonstrates action of CTLA-4 with CD80 or CD86 molecules on
that intracellular CTLA-4 is directed towards the activat- APCs. However, it remains possible that CD80 and CD86
ing anti-CD3 MAb on the glass coverslip. Since CTLA-4 expressed by the alloantigen-presenting cells used in
functions as a cell surface receptor, it was of interest Figure 5 may modify the kinetics or the extent of polar-
to determine whether cell surface CTLA-4 also showed ization.
directional localization. In cells permeabilized prior to
staining with anti-CTLA-4 MAb (see Figure 3H), CTLA-4 Reorientation of Polarized Expression of CTLA-4
accumulated very near the plane of the cell surface and Up-Regulation of Cell Surface Expression
membrane. In other experiments, T cells were activated We next asked whether intracellular CTLA-4 expression
on previously activated T cells would become polarizedas in Figure 3, but stained with anti-CTLA-4 MAb without
Immunity
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Figure 3. Focal Localization of CTLA-4 Near Sites of Immobilization of Activated T Cells by Anti-CD3 MAb
Shown are confocal micrographs of T lymphocytes immobilized by anti-CD3 MAb and stained for various other T cell markers. Peripheral
blood mononuclear cells were activated by binding to anti-CD3 MAb immobilized on glass coverslips. After 2 days of activation, immobilized
cells were fixed in situ, permeabilized, and stained (red fluorescence) for expression of CD28 (A±D), CTLA-4 (E±J), CD2 (K), or CD5 (L); nuclei
(green fluorescence) were counterstained with YO-PRO-1. (A±C) and (E±G) are serial horizontal (XY) optical sections (z50 nM thick) taken at
3 mM intervals beginning in the approximate plane of the coverslip (A and E). (D) and (H) are vertical (XZ) sections from the same cells shown
in (A±C) and (E±G), respectively. (I±L) are vertical sections from different cells. CS, indicates plane of the coverslip.
when these cells were immobilized upon MAb-coated coverslips did not show focal accumulation of CTLA-4
beneath the nucleus, adjacent to the coverslip; mostcoverslips. Peripheral blood mononuclear cells were ac-
tivated in solution with PHA, which leads to a randomly commonly, these cells showed patches of surface fluo-
rescence away from the coverslip (Figures 6F and 6H).oriented distribution of CTLA-4 (Leung et al., 1995). Cells
were then collected and immobilized on anti-CD3- Thus, focal accumulation of cell surface CTLA-4 was
observed within 2±6 hr after immobilization on anti-CD3coated or anti-CD18 MAb-coated coverslips (Figure 6).
When cells were immobilized for 6 hr upon anti-CD3- MAb-coated coverslips.
coated coverslips, many showed intracellular CTLA-4
beneath the nucleus, oriented towards the plane of the Induction of CTLA-4 Export to the Cell Surface
The rapid focal accumulation of cell surface CTLA-4coverslip (Figure 6A for a low power view and 6C for
higher magnification of a vertical section of a typical suggests mobilization of preeÈ xisting CTLA-4 from intra-
cellular stores. To test whether intracellular CTLA-4cell). Cells immobilized upon anti-CD18-coated cov-
erslips showed a different distribution of CTLA-4, with could be induced to accumulate on the cell surface, we
tested various T cell stimuli for their abilities to increasestaining most prominent alongside the nucleus (Figures
6B and 6D). Thus, immobilized anti-CD3 MAb but not cell surface expression of CTLA-4. Addition of anti-CD28
MAb 9.3 to PHA blasts did not increase cell surfaceanti-CD18 MAb caused reorientation of intracellular
CTLA-4 towards the plane of the coverslip within 6 hr. expression of CTLA-4. We also tested pharmacological
agents for their abilities to stimulate cell surface expres-In a similar experiment, we examined the kinetics of
redistribution of cell surface CTLA-4 following immobili- sion of CTLA-4 (Figure 7, top). Phorbol myristate acetate
(PMA) modestly increased cell surface expression ofzation on anti-CD3-coatedcoverslips. Initially, there was
no particular orientation of CTLA-4 with respect to the CTLA-4. A more pronounced affect was obtained with
the calcium ionophore ionomycin, which rapidly in-coverslip, butafter 2 hr of incubation, focal accumulation
of CTLA-4 adjacent to the coverslip could be seen on creased CTLA-4 cell surface expression at 378C. This
increase was maximal within 30 min, and began to de-some cells. Focal accumulation of CTLA-4 was greater
after4 hr (Figures 6E and 6G) and didnot increase further crease within 1±2 hr. In parallel experiments (data not
shown), this increase was not observed when cells wereafter 6 hr. Cells incubated on anti-CD18 MAb-coated
Focal Localization of CTLA-4
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Figure 4. CTLA-4 Is Localized Towards Sites
of T Cell Activation Rather than Adhesion to
the Coverslip
Peripheral blood mononuclear cells were im-
mobilized on anti-CD18 MAb-coated cov-
erslips for 3 days, and activated with anti-CD3
MAb-coated beads. Cells were then fixed in
situ, permeabilized, and stained for CTLA-4
(red fluorescence) and YO-PRO-1 (green fluo-
rescence), as in Figure 3. (A±C) are serial hori-
zontal optical sections (z50 nM thick) taken
at 3 mM intervals beginning in the approxi-
mate plane of the coverslip (A). (D) is a vertical
section from the same cell. Arrows indicate
sites of attachment of 5 mM diameter anti-
CD3-coated beads; CS, coverslip.
incubated at 48C. Other experiments showed this induc- agents increased the rate of uptake, with PMA causing
a greater effect than ionomycin. Thus, the increasedtion was blocked by addition of the calcium-specific
chelator EGTA, indicating that induction was calcium cell surface expression of CTLA-4 caused by ionomycin
could not be attributed to decreased uptake, suggestingdependent. Thus, raising intracellular calcium ion con-
centration leadsto rapid inductionof CTLA-4 expression that the rate of export was increased by this treatment.
at the cell surface.
The increase in cell surface CTLA-4 induced by iono- Expression of CTLA-4
in Perforin-Containing Vesiclesmycin could result either from increased export or de-
creased rate of internalization. To distinguish between The release of perforin-containing granules by cytotoxic
T cells is a Ca21-dependent and directional processthese possibilities, we measured the effects of PMA
and ionomycin on uptake (or internalization) of BODIPY- (Berke, 1994). The parallels between this directional re-
lease and the focal localization of CTLA-4 expressionconjugated anti-CTLA-4 MAb (Figure 7, bottom). Both
Figure 5. CTLA-4 in Activated CD41 Cells Is Localized Towards Alloantigen-Presenting Cells
Lymphoblastoid cells were immobilized on anti-CD20-coated coverslips. Alloreactive CD41 T cells were then added and cultured at 378C for
24 hr. Cells were then fixed and permeabilized, and stained for CTLA-4 (red fluorescence) and nucleic acids (green fluorescence) as in
Figure 3. Left, a horizontal optical section; right, a vertical section. Arrows indicate immobilized lymphoblastoid cells identified by their size
and nuclear morphology.
Immunity
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Figure 6. Redirection of CTLA-4 Expression Following Attachment to Anti-CD3 MAb but Not Anti-CD18 MAb
Peripheral blood mononuclear cells were activated by PHA stimulation for 3 days, then immobilized on glass coverslips coated with anti-
lymphocyte MAbs, and stained with biotinylated anti-CTLA-4 followed by PESA (red fluorescence) and with YO-PRO-1 (green fluorescence).
In (A±D), cells were immobilized for 6 hr, fixed in situ, permeabilized and stained. (A±B) are horizontal nonconfocal images (pinhole fully open),
and (C±D) are vertical confocal images of cells immobilized on anti-CD3 MAb (A, C) or anti-CD18 MAb (B, D). In (E±H), cells were immobilized
for 4 hr and stained prior to permeabilization. (E) and (F) are horizontal nonconfocal images, while (G) and (H) are vertical confocal images of
cells immobilized on anti-CD3 MAb (E, G) or anti-CD18 MAb (F, H). Scale bar on (A) is also appropriate for (B), (E), (F); the bar in (C) is
appropriate for (D), (G), (H).
suggested a possible relationship between vesicles was taken up into endocytic compartments (Ledbetter
et al., 1990). In addition, the amount of cell-associatedcontaining perforin and those containing CTLA-4. We
examined this possibility by testing PHA blasts having anti-CTLA-4 MAb increased with time. This suggests
continuous accumulation of MAb in a compartmentreoriented localization of CTLA-4 (as in Figure 7) for
colocalization of perforin and CTLA-4 intracellular stain- where it was resistant to degradation. Moreover, the
rate of uptake was slow and continuous, and did noting. Vesicles containing both molecules tended to be
oriented towards the plane of the coverslip, with CTLA- readily show saturation with respect to time. Finally, Fab
fragments of anti-CTLA-4 MAb were taken up equally4-containing vesicles generally being more proximal to
the plane of the coverslip and those containing perforin as well as intact MAb, indicating that cross-linking of
CTLA-4 by bivalent MAb was not required for uptake.being more distal. As shown in Figure 8, numerous vesi-
cles stained positive for both CTLA-4 and perforin (indi- The uptake of anti-CTLA-4 MAb without accumulation
at the cell surface suggests that in contrast with CD28,cated by the arrows). Thus, vesicles containing internal
stores of CTLA-4 and those containing perforin were CTLA-4 cycles continuously to and from the cell surface.
Intracellular levels of anti-CTLA-4 MAb that accumulateadjacent and sometimes overlapped. We have also ob-
served colocalization of CTLA-4-containing and per- over time are higher than those at the cell surface, sug-
gesting that endocytosis from the cell surface is rapidforin-containing vesicles in alloreactive T cell blasts
(data not shown). compared with export of CTLA-4 to the cell surface.
Other data also support cycling of CTLA-4 to and from
the cell surface. The overlap of transferrin-containing
endocytic vesicles with intracellular stores of CTLA-4Discussion
indicates that even in the absence of anti-CTLA-4 MAb,
CTLA-4 is found in intracellular compartment(s) that traf-We have shown that anti-CTLA-4 MAb or Fab fragments
are endocytosed by activated T cells. In contrast, CD28 fic to and from the cell surface. In addition, levels of
CTLA-4 at the cell surface can be increased by raisingexpression was not modulated by MAbs. MAbs to many
cell surface antigens are internalized under the condi- intracellular calcium levels. Since this increase was not
accompanied by a decrease in the rate of internalization,tions utilized here, so the uptake of anti-CTLA-4 MAbs
was not necessarily unique. However several features it was therfore probably due to increased mobilization
from intracellular stores. Furthermore, we observed co-of the uptake of anti-CTLA-4 MAb were noteworthy. The
amount of anti-CTLA-4 MAb internalized exceeded the localization of a fraction of CTLA-4-containing vesicles
with perforin-containing vesicles. Electron micrographicamount bound to the cell surface at any point in time
(compare Figures 1C and 1D). This differs from the situa- studies have shown that perforin-containing vesicles
are secretory lysosomes (Peters et al., 1991). Thus, thetion in which anti-CD3 MAb initially gave high levels of
cell surface expression, which then decreased as MAb distribution of intracellular CTLA-4 overlaps with both
Focal Localization of CTLA-4
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Figure 8. Colocalization of CTLA-4 and Perforin-Containing Ves-
icles
PHA blasts were incubated on glass coverslips coated with anti-
CD3 MAb G19-4 for 2 hr to allow redirection of CTLA-4 expression
as in Figure 6. Cells were then fixed and permeabilized and stained
with biotinylated anti-CTLA-4 MAb 10A8, followed by PESA (red
fluorescence) and FITC-conjugated anti-perforin MAb (green fluo-
rescence). Areas of coincidence of red and green fluorescence (giv-
ing yellow fluorescence) indicate overlapping distribution of CTLA-4
and perforin; some of these areas are indicated by arrows. (A±D)
show serial optical sections through the same field of cells, z1.5
mm apart, beginning in the plane of the coverslip (A) and continuing
upwards.
simply triggering CTLA-4 molecules on the cell surface,
Figure 7. Calcium Ionophore Induces Increased Expression of
anti-CTLA-4 MAbs and Fabs are efficiently and steadilyCTLA-4 at the Cell Surface
internalized into endosomes. This is in contrast withPHA blasts were treated with medium alone (circles), PMA (10 ng/
anti-CD28 MAbs, which are more readily retained at theml, squares), or ionomycin (1 mg/ml, triangles) for increasing periods
cell surface. Since CTLA-4 and CD28 are differentiallyof time at 378C.
(Top) Cell surface staining for CTLA-4. Following incubation with the modulated by MAbs, MAb-triggered signals through
indicated agents, cells were washed and incubated with biotinylated these molecules may have different relevance as mimics
MAbs at 48C for 1 hr. Cells were then washed again, incubated with of cell surface stimulation by CD80/CD86 ligands. It will
PESA at 48C, and analyzed by flow cytometry. Cells stained with
be important to determine whether the distribution ofbiotinylated-negative control MAb ME20 gave mean fluorescence
CTLA-4 is correlated with the differing effects of anti-intensities of z7.
CTLA-4 MAbs upon T cell activation under different con-(Bottom) Uptake of anti-CTLA-4 MAb. Cells were incubated with
ditions (Krummel and Allison, 1995).BODIPY-conjugated anti-CTLA-4 MAb 11D4 together with the indi-
cated agents. After incubation for the indicated periods of time, Under some circumstances, CD28±B7 interactions
cells were washed and uptake of anti-CTLA-4 MAb was measured may regulate the effector phase of cell-mediated cytoly-
as indicated in Figure 1. Each experiment was performed at least sis (Ramarathinam et al., 1994; Azuma et al., 1992). The
twice and gave identical results.
role of CTLA-4 in this process has not been determined.
Our observation of colocalization of CTLA-4-containing
secretory and endocytic compartments. Taken to- and perforin-containing vesicles suggests a new avenue
gether, these data suggest that CTLA-4 expression at of investigation into whether CTLA-4 plays a role in the
the cell surface is dynamically regulated by its transit formation, release, or both, of perforin-containing ves-
between intracellular stores and the cell surface. icles.
Addition of intact anti-CTLA-4 MAbs or Fab fragments Intracellular and cell surface CTLA-4 became focally
to several in vitro and in vivo systems stimulates T cell localized towards sites of TCR cross-linking. Focal local-
activation (Linsley et al., 1992; Walunas et al., 1994; ization of cell surface CTLA-4 could result from its co-
Krummel and Allison, 1995), whereascross-linking these capping with components of the TCR during incubation
MAbs inhibits T cell activation (Krummel and Allison, with immobilized anti-CD3 MAb. We consider this un-
1995). These studies have been interpreted as mimick- likely because intracellular CTLA-4 was also focally lo-
ing the interaction of cell surface CTLA-4 with its B7 calized, and there is no obvious direct connection be-
tween intracellular CTLA-4 and that on the cell surface.ligands. However, we have shown here that rather than
Immunity
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Experimental ProceduresAlso arguing against a cocapping mechanism is the find-
ing that CD2, CD4, and CD5, which may associate with
Cell Culturethe TCR during T cell activation, show a more uniform
Human peripheral blood mononuclear cells were activated by cul-
distribution. ture (Linsley et al., 1991; Leung et al., 1995) with 1 mg/ml PHA for
An alternative explanation for focal localization of cell 3 days, or by incubation for 2±3 days (at 2.5 3 106/well) on anti-CD3
surface CTLA-4 is that lymphocytes may directionally MAb G19-4-coated 4 cm2 chambered coverslips (Nunc, Naperville,
Illinois). Alloreactive CD41 cells were cultured as described usingregulate cell surface membrane protein organization.
Epstein±Barr virus±transformed B lymphoblastoid cells as stimula-Polarization of intracellular CTLA-4 and that which is
tors (Linsley et al., 1991). Polystyrene beads (5 mM in diameter,newly inserted into the cellmembrane could be achieved
IDC, Portland, Oregon) were coated with MAb G19±4 as described
by vectorial organization of the lymphocyte secretory (Krummel and Allison, 1995).
apparatus during cell activation, analogous to direc-
tional cytokine release (Singer, 1992; Poo et al., 1988;
MAbsKupfer et al., 1991, 1994). Polarization of cell surface
Anti-CTLA-4 MAbs, 11D4, 7F8, and 10A8 have been previously de-
CTLA-4 would be maintained if the rate of internalization scribed (Linsley et al., 1992). Fab fragments of MAb 11D4 were
exceeded the rate of export as distance from the site prepared by M. Stebbins (Bristol-Myers Squibb Pharmaceutical Re-
of TCR engagement increased. This predicted rapid rate search Institute [BMSPRIS], Seattle, Washington). These were
shown by gel permeation chromatography to contain undetectableof internalization is consistent with our data showing
amounts of aggregated material. CTLA-4Ig was prepared by Biologi-steady uptake of anti-CTLA-4 MAb by activated T cells.
cal Process Research (BMSPRIS). Anti-CD3 MAb G19-4; anti-CD18In contrast, CD28 (or many other lymphocytecell surface
MAb 60.3; anti-CD20 MAb 1F5; and anti-CD28 MAb 9.3 were pro-
proteins) does not show polarized distribution, nor does vided by Dr. J. Ledbetter (BMSPRIS). Negative control MAbs 52.4
it show this apparent cycling from the cell surface. The (anti-decapeptide) and ME20 (anti-human melanoma) were provided
molecular mechanisms involved in lymphocyte polariza- by Dr. D. Yelton (BMSPRIS). Anti-CD25 MAb TOT14 was from AMAC
tion are not well understood, although a recent report (Westbrook, Maine). Anti-CD2, anti-CD4, anti-CD5, and anti-CD69
MAbs were purchased from Becton Dickinson (San Jose, California).demonstrated the involvement of the Ras-related
Control murine immunoglobulin G1 was purchased from Phar-GTPase CDC42 in this process (Stowers et al., 1995).
mingen (San Diego, California). Anti-perforin MAb dG9 was fromFocal localization of CTLA-4 towards sites of TCR
Ancell (Bayport, Minnesota). Biotinylated and fluoroscein isothiocy-
engagement may serve to regulate the specificity of anate±conjugated MAbs were purchased from the indicated suppli-
CTLA-4±CD80/CD86 interactions. Since CTLA-4 has ers or were prepared using standard techniques. BODIPY FL amine
high avidity for CD80/CD86 molecules, its unregulated labeling reagent was purchased from Molecular Probes (Eugene,
expression could lead to engagement by CD80/CD86 Oregon). Cy5 reactive dye was purchased from Biological Detection
Systems (Pittsburgh, Pennsylvania). BODIPY- and Cy5-conjugatedmolecules on APCs not displaying appropriate antigenic
MAbs or Fab fragments, or both, were prepared according to thepeptides. This presents a problem for maintaining the
instructions of the manufacturers. Analysis by gel permeation chro-antigen specificity of CTLA-4±CD80/CD86 interactions.
matography of BODIPY-conjugated Fab fragments of MAb 11D4
With cytokines, the problem of functional specificity is showed that the conjugation procedure did not result in detectable
solved by their focal release, thereby concentrating formation of aggregates.
them near APCs interacting with antigen-specific T cells
(Poo et al., 1988; Kupfer et al., 1991, 1994). In an analo- Immunostaining
gous fashion, focal localization of CTLA-4 may limit its MAbs were used at concentrations of 2±10 mg/ml. Staining of cell
functional engagement to APCs bearing only specific surface antigens was performed at 48C in staining medium (DMEM
peptides. containing 10% fetal bovine serum, 10 mM EDTA, 0.1% NaN3, and
10 mM HEPES [pH 7.2]). For staining of intracellular antigens, cellsCycling and focal localization of CTLA-4 may also
were fixed for 5 min at 378C in fixative solution (phosphate-bufferedhelp couple CTLA-4 engagement with the strength of
saline [PBS]) containing 4% EM grade paraformaldehyde (Poly-an immune response. Data presented here show that
sciences, Warrington, Pennsylvania) and 0.1% saponin. Cells were
CTLA-4 expression at the cell surface is a dynamic pro- then washed with PBS, blocked in binding medium containing
cess and is directionally regulated by TCR engagement. 0.05% saponin, then stained in the same medium. Staining with
Other recent evidence suggests that TCR/peptide±MHC biotinylated MAbs was followed by addition of R-phycoerythrin-
interactions are also dynamic and reversible (Valitutti et conjugated streptavidin (PESA,Molecular Probes, Eugene, Oregon),
After staining, cells were washed in PBS. Cells used for confocalal., 1995). These authors have suggested that a single
microscopy were then incubated in fixative solution for 5 min beforepeptide±MHC complex serially engages and triggers
analysis. Nuclei, cytoplasm, or both, were counterstained by DNAmany TCRs, a process encouraged by the low avidity
binding dyes (from Molecular Probes, Eugene, Oregon), YO-PRO-1
and fast kinetic off rates of TCR/peptide±MHC interac- (30 nM, green fluorescence), or propidium iodide (0.1 mg/ml, red
tions. fluorescence).
Together, these findings lead us to speculate that
CTLA-4 expression at the cell surface, and hence its Fluorescence Analysis
ability to regulate immune responses, is directly related Flow cytometry was performed using a 488 nM laser on a FACScan
to the strength of TCR/peptide±MHC interactions. This (Becton Dickinson). BODIPY fluorescence was monitored in channel
in turn suggests that stronger TCR/peptide±MHC inter- 1 and PESA fluorescence in channel 2. Confocal microscopy was
performed on Leica CLSM, or Bio-Rad MRC-1024 model confocalactions would be most prone to productive signaling
microscopes. Green fluorescence was detected following excitationand, therefore, would be more likely to result in induction
at 488 nM; red fluorescence, following excitation at 488 nM (PESA)of CTLA-4 expression. The functional consequences of
or 565 nM (PESA and Texas Red); and blue fluorescence, at 646
CTLA-4 engagement would thus be more pronounced nM. Images were recorded as TIF files and processed (Adobe Pho-
for stronger TCR interactions driven either by higher toshop, Adobe Systems, Mountainview, California) to subtract back-
TCR avidity (slower off rates) or by higher occupancy ground and to enhance lower and middle intensity fluorescence.
Separate panels in each individual figure were processed identically.at elevated antigen concentrations.
Focal Localization of CTLA-4
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Endocytosis Assays Ledbetter, J.A., June, C.H., Hu, S.-l., and Press, O.W. (1990). Regula-
tion of cytoplasmic calcium concentration in T cells. In Immunoge-To measure uptake of anti-CTLA-4 and anti-CD28 MAbs, cells were
incubated with BODIPY- or FITC-conjugated MAbs for various peri- nicity, C.A. Janeway, Jr., J. Sprent, and E. Sercarz, eds. (New York:
Wiley-Liss), pp. 113±123.ods of time at 378C. Uptake of fluorescent MAb was then measured
by flow cytometry or confocal microscopy. Initial experiments were Leung, H.T., Bradshaw, J., Cleaveland, J., and Linsley, P.S. (1995).
performed using BODIPY-conjugated MAbs, since the emission of Cytotoxic T lymphocyte±associated molecule-4, a high avidity re-
this fluorophore is not quenched at the acidic pH characteristic of ceptor for CD80 and CD86, contains an intracellular localization
some intracellular vesicular compartments. However, in later experi- motif in its cytoplasmic tail. J. Biol. Chem. 270, 25107±25114.
ments, identical results were obtained using FITC-conjugated MAbs. Linsley, P.S., and Ledbetter, J.A. (1993). The role of the CD28 recep-
Steady-state labeling of transferrin-containing endosomes was per- tor during T cell responses to antigen. Annu. Rev. Immunol. 11,
formed by incubating PHA blasts with TRTf (Molecular Probes) for 191±212.
1 hr at 378C. To colocalize TRTf-containing endocytic vesicles and
Linsley, P.S., Brady, W., Urnes, M., Grosmaire, L.S., Damle, N.K.,intracellular CTLA-4, cells were then fixed and permeabilized, and
and Ledbetter, J.A. (1991). CTLA-4 is a second receptor for the Bintracellular CTLA-4 was stained with BODIPY-conjugated MAb
cell activation antigen B7. J. Exp. Med. 174, 561±569.11D4. Colocalization of vesicles containing CTLA-4 with those con-
Linsley, P.S., Greene, J.L., Tan, P., Bradshaw, J., Ledbetter, J.A.,taining perforin was performed by adding to fixed and permeabilized
Anasetti, C., and Damle, N.K. (1992). Coexpression and functionalcells a mixture of anti-CTLA-4 MAb and anti-perforin MAb.
cooperation of CTLA-4 and CD28 on activated T lymphocytes. J.
Exp. Med. 176, 1595±1604.
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